Genes, p53: Clinical Trials

8 trials of Genes, p53, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 3 completed. 3 Phase 2, 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 2, Completed 1
Phase 42Unknown 2
Not applicable1Unknown 1

Follow Genes, p53: new trials by email Literature Review of Genes, p53 trials Research Report on Genes, p53

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence
P53, Ki67 and Cyclin A IHC. - Wilms Tumor, Relapse
Not applicableUnknownMansoura University752021-02-142021-02-17
Association Between Ferroptosis and Epilepsy
SLC7A11, GPX4, P53 - Epilepsy
CompletedAffiliated Hospital of Jiangnan University402021-01-202022-04-15
Signaling Pathways Targeting Colorectal Cancer in Egypt
Markers in tissue samples: (TIGAR , TRIM59, P53, AKT, GSH) - Colorectal Cancer
CompletedAssiut University1802018-03-012020-05-11
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
p53 gene, Cisplatin, Paclitaxel - Ovarian Epithelial Cancer, Fallopian Tube Cancer
Phase 2UnknownShenzhen SiBiono GeneTech Co.,Ltd1002015-06-012015-05-06
Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma
TAE plus P53 gene, TAE - Advanced Hepatocellular Carcinoma (HCC)
Phase 2UnknownShenzhen SiBiono GeneTech Co.,Ltd602014-10-012015-07-27
rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors
p53 gene with surgery, surgery, p53 with chemotherapy - Advanced Oral and Maxillofacial Malignant Tumors
Phase 4UnknownShenzhen SiBiono GeneTech Co.,Ltd6002009-06-012012-04-09
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
chemotherapy plus p53, chemotherapy, radiotherapy - Neoplasms
Phase 4UnknownShenzhen SiBiono GeneTech Co.,Ltd12002009-05-012012-04-09
Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes
anti-protein 53 or tumor protein 53 (p53) T-cell receptor transduced peripheral blood lymphocytes, aldesleukin, filgrastim - Anti-p53 TCR-Gene
Phase 2CompletedNational Cancer Institute (NCI)122006-10-012011-08-15

Conditions studied

Neoplasms (3)  ·  Recurrence (2)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Carcinoma, Renal Cell (1)  ·  Colorectal Neoplasms (1)  ·  Death (1)  ·  Epilepsy (1)  ·  Fallopian Tube Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Ovarian Neoplasms (1)  ·  Wilms Tumor (1)

Sponsors

Shenzhen SiBiono GeneTech Co.,Ltd (4)  ·  Affiliated Hospital of Jiangnan University (1)  ·  Assiut University (1)  ·  Mansoura University (1)  ·  National Cancer Institute (NCI) (1)

Countries

China (5)  ·  Egypt (2)  ·  United States (1)

Top investigators

Adel Nabeeh, MD (1)  ·  Ahmed Ali Abdel Motelb, lecturer (MD) (1)  ·  Ashraf Hafez, MD (1)  ·  Asmaa Alaaeldeen Kamal, MD (PhD student) (1)  ·  Longjiang Li, PhD, MD (1)  ·  Marwa AbdelHafiz Abdel Hassan, lecturer (MD) (1)  ·  Mohamed Abdelhameed, MSc (1)  ·  Ragaa Hamdy Salama, Professor (MD) (1)  ·  Steven A Rosenberg, M.D., Ph.D (1)  ·  Tamer Helmy, MD (1)  ·  YueYing Liu (1)